The procoagulant and proinflammatory plasma contact system (Q37920779)

25 August 2017

1 reference

title

The procoagulant and proinflammatory plasma contact system (English)

1 reference

25 August 2017

Thomas Renné

1 reference

25 August 2017

publication date

20 August 2011

1 reference

Seminars in Immunopathology

25 August 2017

published in

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

31-41

1 reference

Triggers, targets and treatments for thrombosis

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Novel roles for factor XII-driven plasma contact activation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

The intrinsic pathway of coagulation: a target for treating thromboembolic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Factor XI activation in a revised model of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Role of tissue factor in hemostasis, thrombosis, and vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Defective thrombus formation in mice lacking coagulation factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Coagulation in vertebrates with a focus on evolution and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Role of Factor XII in hemostasis and thrombosis: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Factor XI contributes to thrombin generation in the absence of factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Factor XI deficiency in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Evidence of a U-shaped association between factor XII activity and overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Activation of the classical pathway of complement by Hageman factor fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Hereditary angioedema with normal C1-inhibitor activity in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Bradykinin-mediated angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Disease expression in women with hereditary angioedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Intrinsic pathway of coagulation and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Kinin formation: mechanisms and role in inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Heparin, derived from the mast cells of human lungs is responsible for the generation of kinins in allergic reactions due to the activation of the contact system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Mast-cell responses to pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Heparin is essential for the storage of specific granule proteases in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Activation of the contact-phase system on bacterial surfaces--a clue to serious complications in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Clinical practice. Hereditary angioedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Contaminated heparin associated with adverse clinical events and activation of the contact system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Biochemical and pharmacologic inequivalence of low molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Aggregation of platelets by collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Dual role of collagen in factor XII-dependent thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Polyphosphate modulates blood coagulation and fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Platelet polyphosphates: the nexus of primary and secondary hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Availability of Platelet Factor 3 and Activation of Factor XII in Thrombasthenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0288-2

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation

21 January 2018

1 reference

12 December 2020

Hageman factor deficiency and oral contraceptives

1 reference

12 December 2020

Feedback controversy stops here

1 reference

12 December 2020

Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen

1 reference

12 December 2020

Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.

1 reference

12 December 2020

Polyphosphates: a link between platelet activation, intrinsic coagulation and inflammation?

1 reference

12 December 2020

Ecallantide for the treatment of acute attacks in hereditary angioedema

1 reference

12 December 2020

In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E

1 reference

12 December 2020

Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.

1 reference

12 December 2020

Factor XII activation is essential to sustain the procoagulant effects of particulate matter

1 reference

12 December 2020

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

1 reference

12 December 2020

Activation of the coagulation cascade in C1-inhibitor deficiencies.

1 reference

12 December 2020

Local bradykinin formation is controlled by glycosaminoglycans

1 reference

12 December 2020

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

1 reference

12 December 2020

Contact activation factors in plasma from pregnant women--increased level of an association between factor XII and kallikrein

1 reference

12 December 2020

Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors

1 reference

12 December 2020

Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies

1 reference

12 December 2020

Activation of Hageman factor by collagen

1 reference

12 December 2020

A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques

1 reference

12 December 2020

Mast cell derived heparin activates the contact system: a link to kinin generation in allergic reactions

1 reference

12 December 2020

Decreased in vitro thrombin generation and clot stability in human FXII-null blood and plasma

1 reference

12 December 2020

Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema

1 reference

12 December 2020

Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00281-011-0288-2

Identifiers

DOI

1 reference

25 August 2017

1 reference